rxstat › Shortages › Brivaracetam
Brivaracetam shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Brivaracetam products are in shortage in Canada (1 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Apr 3, 2026.
In shortage since
Jan 6, 2026
Est. full return
Apr 3, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-BRIVARACETAM
25MG · TABLET · APOTEX INC
DIN 02538687 · since Jan 6, 2026, est. end Apr 3, 2026 · Disruption of the manufacture of the drug.
ResolvedAPO-BRIVARACETAM
100MG · TABLET · APOTEX INC
DIN 02538717 · ended Apr 2, 2026 · Disruption of the manufacture of the drug.
ResolvedAPO-BRIVARACETAM
50MG · TABLET · APOTEX INC
DIN 02538695 · ended Apr 2, 2026 · Disruption of the manufacture of the drug.
ResolvedAPO-BRIVARACETAM
75MG · TABLET · APOTEX INC
DIN 02538709 · ended Mar 12, 2026 · Disruption of the manufacture of the drug.
ResolvedAPO-BRIVARACETAM
75MG · TABLET · APOTEX INC
DIN 02538709 · ended Feb 13, 2025 · Disruption of the manufacture of the drug.
ResolvedAPO-BRIVARACETAM
50MG · TABLET · APOTEX INC
DIN 02538695 · ended Feb 13, 2025 · Disruption of the manufacture of the drug.
ResolvedBRIVLERA
10MG · SOLUTION · UCB CANADA INC
DIN 02452987 · ended Jun 12, 2024 · Demand increase for the drug.
ResolvedBRIVLERA
10MG · SOLUTION · UCB CANADA INC
DIN 02452987 · ended Jan 18, 2022 · Demand increase for the drug.
ResolvedBRIVLERA
10MG · SOLUTION · UCB CANADA INC
DIN 02452987 · ended Nov 5, 2021 · Demand increase for the drug.
ResolvedBRIVLERA
10MG · SOLUTION · UCB CANADA INC
DIN 02452987 · ended Jan 15, 2021 · Delay in shipping of the drug.
ResolvedBRIVLERA
25MG · TABLET · UCB CANADA INC
DIN 02452944 · ended Jun 8, 2020 · Delay in shipping of the drug.
ResolvedBRIVLERA
10MG · TABLET · UCB CANADA INC
DIN 02452936 · ended Jun 2, 2020 · Delay in shipping of the drug.
Showing 12 of 13 reports. All reports are on file with Health Canada.
What's happening
Brivaracetam is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Brivaracetam is classified under “ANTIEPILEPTICS” (ATC N03AX).
Recent changes
Common questions
When will Brivaracetam be back in stock in Canada?
The latest manufacturer estimate is Apr 3, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Brivaracetam in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All antiepileptics shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.